Oxford/AstraZeneca COVID-19 vaccine effectiveness in England

Trial Identifier:	D8111R00007
Sponsor:	AstraZeneca
Collaborator:	The Chancellor, Masters and Scholars of the University of Oxford
NCTID::	NCT05047822
Start Date:	August 2021
Primary Completion Date:	January 2023
Study Completion Date:	January 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom, United Kingdom	Leeds, United Kingdom, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.